Cargando…

Prophylactic and therapeutic approaches for human metapneumovirus

Human metapneumovirus (HMPV) is an important pneumovirus which causes acute respiratory disease in human beings. The viral infection leads to mild to severe respiratory symptoms depending on the age and immune status of the infected individual. Several groups across the world are working on the deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Prashant, Srivastava, Mansi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261883/
https://www.ncbi.nlm.nih.gov/pubmed/30539045
http://dx.doi.org/10.1007/s13337-018-0498-5
_version_ 1783375005424287744
author Kumar, Prashant
Srivastava, Mansi
author_facet Kumar, Prashant
Srivastava, Mansi
author_sort Kumar, Prashant
collection PubMed
description Human metapneumovirus (HMPV) is an important pneumovirus which causes acute respiratory disease in human beings. The viral infection leads to mild to severe respiratory symptoms depending on the age and immune status of the infected individual. Several groups across the world are working on the development of immunogens and therapy to manage HMPV infection with promising results under laboratory conditions but till date any virus specific vaccine or therapy has not been approved for clinical use. This minireview gives an overview of the prophylactic and therapeutic approaches to manage HMPV infections.
format Online
Article
Text
id pubmed-6261883
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-62618832019-12-01 Prophylactic and therapeutic approaches for human metapneumovirus Kumar, Prashant Srivastava, Mansi Virusdisease Review Article Human metapneumovirus (HMPV) is an important pneumovirus which causes acute respiratory disease in human beings. The viral infection leads to mild to severe respiratory symptoms depending on the age and immune status of the infected individual. Several groups across the world are working on the development of immunogens and therapy to manage HMPV infection with promising results under laboratory conditions but till date any virus specific vaccine or therapy has not been approved for clinical use. This minireview gives an overview of the prophylactic and therapeutic approaches to manage HMPV infections. Springer India 2018-10-20 2018-12 /pmc/articles/PMC6261883/ /pubmed/30539045 http://dx.doi.org/10.1007/s13337-018-0498-5 Text en © Indian Virological Society 2018
spellingShingle Review Article
Kumar, Prashant
Srivastava, Mansi
Prophylactic and therapeutic approaches for human metapneumovirus
title Prophylactic and therapeutic approaches for human metapneumovirus
title_full Prophylactic and therapeutic approaches for human metapneumovirus
title_fullStr Prophylactic and therapeutic approaches for human metapneumovirus
title_full_unstemmed Prophylactic and therapeutic approaches for human metapneumovirus
title_short Prophylactic and therapeutic approaches for human metapneumovirus
title_sort prophylactic and therapeutic approaches for human metapneumovirus
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261883/
https://www.ncbi.nlm.nih.gov/pubmed/30539045
http://dx.doi.org/10.1007/s13337-018-0498-5
work_keys_str_mv AT kumarprashant prophylacticandtherapeuticapproachesforhumanmetapneumovirus
AT srivastavamansi prophylacticandtherapeuticapproachesforhumanmetapneumovirus